Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000031 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
873
Total Value
$19,369.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VP/Chief Accounting Officer | Common Stock | โ | Jan 13, 2026 | Sale | 873 | $22.19 | $19,369.43 | 52,595 | Direct | โ | View Details |